A phase 2, single-arm study of volociximab (an anti-a5 beta 1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer Meeting Abstract
| Authors: | Matthews, C. M.; Ho, S. N.; Barve, M.; Bell-Mcguinn, K. M.; Gilbert, L.; Penson, R. T.; Lengyel, E.; Weymer, S.; Gilder, K.; Schilder, R. J. |
| Abstract Title: | A phase 2, single-arm study of volociximab (an anti-a5 beta 1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer |
| Meeting Title: | 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | EJC Supplements |
| Volume: | 6 |
| Issue: | 12 |
| Meeting Dates: | 2008 Oct 21-24 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 1359-6349 |
| Publisher: | Pergamon-Elsevier Science Ltd |
| Date Published: | 2008-10-01 |
| Start Page: | 164 |
| End Page: | 165 |
| Language: | English |
| ACCESSION: | WOS:000261221200516 |
| DOI: | 10.1016/s1359-6349(08)72453-4 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 519 - Poster - 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - OCT 21-24, 2008 - Geneva, SWITZERLAND - "Source: Wos" |
